Mersana Therapeutics, Inc. (MRSN)
28.24
+0.13
(+0.46%)
USD |
NASDAQ |
Dec 11, 16:00
28.24
0.00 (0.00%)
After-Hours: 20:00
Mersana Therapeutics Cash from Investing (Quarterly): 0.372M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Day One Biopharmaceuticals, Inc. | 13.46M |
| Cidara Therapeutics, Inc. | -176.47M |
| Cue Biopharma, Inc. | -6.768M |
| Scholar Rock Holding Corp. | 59.70M |
| ETHZilla Corp. | -252.37M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.192M |
| Cash from Financing (Quarterly) | -17.76M |
| Free Cash Flow | -74.37M |
| Free Cash Flow Per Share (Quarterly) | -0.6393 |
| Free Cash Flow to Equity (Quarterly) | 15.14M |
| Free Cash Flow to Firm (Quarterly) | -3.176M |
| Free Cash Flow Yield | -4.08% |